Virtually all pharmaceutical manufacturers have robust policies to place needed medicines in the hands of those who cannot afford to pay for them.
PRESIDENT | CORBETT WORLDWIDE HEALTHCARE COMMUNICATIONS
Ironically, pharma has many patient assistance programs already firmly in place (established well before the current economic downturn). There is probably no other industry in America that has as many established initiatives to assure continuity of care for the customer.
Virtually all pharmaceutical manufacturers have robust policies to place needed medicines in the hands of those who cannot afford to pay for them. Although this is certainly not an exhaustive list, what follows is merely a portion of the programs that pharma has sponsored to safeguard the health of patients: the AstraZeneca Prescription Savings Program, the Merck Patient Assistance Program, the Alcon U.S. Patient Assistance Program, the Pfizer Friends Program, the Bristol-Myers Squibb Patient Assistance Foundation, the Procter & Gamble Pharmaceuticals Patient Assistance Program, and the Sanofi-Aventis Patient Assistance Program. Perhaps pharma needs to "toot its own horn" a little more loudly and recognize that those of us who work in the pharmaceutical industry are dedicated to extending and enhancing human life.
Elaine Eisen
The Future of Fertility: AI, Personalized Medicine, and Ethical Considerations
January 30th 2025Dr. Lawrence B. Werlin, MD, FACOG of HRC Fertility (@md.lawrence.werlin on TikTok), discusses how to combat the spread of misinformation on social media, opportunities that social media presents, advancements in fertility technology, and more.
FDA Approves Roche’s Susvimo Refillable Eye Implant for Diabetic Macular Edema
February 4th 2025Roche’s Susvimo, a refillable eye implant for diabetic macular edema, provides continuous delivery of ranibizumab, showing sustained vision improvements with fewer treatments than standard eye injections.
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.